The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Marking the second global approval after Japan, the U.S. FDA has approved Datroway (datopotamab deruxtecan), a trophoblast cell surface antigen 2-directed antibody-drug conjugate (ADC) from Daiichi ...

It combines a monoclonal antibody, datopotamab, that targets trophoblast cell surface antigen 2 (TROP2), a protein commonly found in high levels on breast cancer cells, with the chemotherapy drug ...

Advanced maternal age (AMA) placenta exhibited premature aging, presumably resulting in trophoblast dysfunction, inadequate placentation. However, the precise reasons and mechanisms of trophoblast ...